PT-141 (Bremelanotide) — melanocortin receptor agonist research peptide. Studied for MC4R-mediated CNS effects.

PT-141 (Bremelanotide) is a 7-amino-acid research peptide derived from MT-2 with structural modifications. Unlike MT-2, it has reduced melanogenic activity and primarily targets MC4R-mediated central pathways.
PT-141 binds MC4R with high affinity in the central nervous system, affecting downstream neural pathways studied in sexual response and other behavioral research.
Used in: MC4R receptor research, central melanocortin signaling studies, comparative MSH analog research.
| Compound | PT-141 (Bremelanotide) |
| Available Strengths | 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.